Continuing declines in cancer mortality in the European Union

Fabio Levi, F. Lucchini, E. Negri, C. La Vecchia

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background: From 1988 to 1997 age-standardised total cancer mortality rates in the European Union (EU) fell by around 9% in both sexes. Available cancer mortality data in Europe up to 2002 allow a first check of the forecast of further declines in cancer mortality. Patients and methods: We considered trends in age-standardised mortality from major cancer sites in the EU during the period 1980-2002. Results: For men, total cancer mortality, after a peak of 191.1/100 000 in 1987 declined to 177.8 in 1997 (-7%), and to 166.5 in 2002. Corresponding figures for females were 107.9/100 000, 100.5 and 95.2, corresponding to falls of 7% from 1987 to 1997, and to 5% from 1997 to 2002. Over the last 5 years, lung cancer declined by 1.9% per year in men, to reach 44.4/100 000, but increased by 1.7% in women, to reach 11.4. In 2002, for the first year, lung cancer mortality in women was higher than that for intestinal cancer (11.1/100 000), and lung cancer became the second site of cancer deaths in women after breast (17.9/100 000). From 1997 to 2002, appreciable declines were observed in mortality from intestinal cancer in men (-1.6% per year, to reach 18.8/100 000), and in women (-2.5%), as well as for breast (-1.7% per year) and prostate cancer (-1.4%). Conclusions: Despite the persisting rises in female lung cancer, the recent trends in cancer mortality in the EU are encouraging and indicate that an 11% reduction in total cancer mortality from 2000 to 2015 is realistic and possible.

Original languageEnglish
Pages (from-to)593-595
Number of pages3
JournalAnnals of Oncology
Volume18
Issue number3
DOIs
Publication statusPublished - Mar 2007

Fingerprint

European Union
Mortality
Neoplasms
Lung Neoplasms
Intestinal Neoplasms
Breast
Second Primary Neoplasms
Prostatic Neoplasms

Keywords

  • Cancer
  • Europe
  • Mortality
  • Time trends

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Levi, F., Lucchini, F., Negri, E., & La Vecchia, C. (2007). Continuing declines in cancer mortality in the European Union. Annals of Oncology, 18(3), 593-595. https://doi.org/10.1093/annonc/mdl437

Continuing declines in cancer mortality in the European Union. / Levi, Fabio; Lucchini, F.; Negri, E.; La Vecchia, C.

In: Annals of Oncology, Vol. 18, No. 3, 03.2007, p. 593-595.

Research output: Contribution to journalArticle

Levi, F, Lucchini, F, Negri, E & La Vecchia, C 2007, 'Continuing declines in cancer mortality in the European Union', Annals of Oncology, vol. 18, no. 3, pp. 593-595. https://doi.org/10.1093/annonc/mdl437
Levi, Fabio ; Lucchini, F. ; Negri, E. ; La Vecchia, C. / Continuing declines in cancer mortality in the European Union. In: Annals of Oncology. 2007 ; Vol. 18, No. 3. pp. 593-595.
@article{a22a5b75b5164cce83b837f701636318,
title = "Continuing declines in cancer mortality in the European Union",
abstract = "Background: From 1988 to 1997 age-standardised total cancer mortality rates in the European Union (EU) fell by around 9{\%} in both sexes. Available cancer mortality data in Europe up to 2002 allow a first check of the forecast of further declines in cancer mortality. Patients and methods: We considered trends in age-standardised mortality from major cancer sites in the EU during the period 1980-2002. Results: For men, total cancer mortality, after a peak of 191.1/100 000 in 1987 declined to 177.8 in 1997 (-7{\%}), and to 166.5 in 2002. Corresponding figures for females were 107.9/100 000, 100.5 and 95.2, corresponding to falls of 7{\%} from 1987 to 1997, and to 5{\%} from 1997 to 2002. Over the last 5 years, lung cancer declined by 1.9{\%} per year in men, to reach 44.4/100 000, but increased by 1.7{\%} in women, to reach 11.4. In 2002, for the first year, lung cancer mortality in women was higher than that for intestinal cancer (11.1/100 000), and lung cancer became the second site of cancer deaths in women after breast (17.9/100 000). From 1997 to 2002, appreciable declines were observed in mortality from intestinal cancer in men (-1.6{\%} per year, to reach 18.8/100 000), and in women (-2.5{\%}), as well as for breast (-1.7{\%} per year) and prostate cancer (-1.4{\%}). Conclusions: Despite the persisting rises in female lung cancer, the recent trends in cancer mortality in the EU are encouraging and indicate that an 11{\%} reduction in total cancer mortality from 2000 to 2015 is realistic and possible.",
keywords = "Cancer, Europe, Mortality, Time trends",
author = "Fabio Levi and F. Lucchini and E. Negri and {La Vecchia}, C.",
year = "2007",
month = "3",
doi = "10.1093/annonc/mdl437",
language = "English",
volume = "18",
pages = "593--595",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Continuing declines in cancer mortality in the European Union

AU - Levi, Fabio

AU - Lucchini, F.

AU - Negri, E.

AU - La Vecchia, C.

PY - 2007/3

Y1 - 2007/3

N2 - Background: From 1988 to 1997 age-standardised total cancer mortality rates in the European Union (EU) fell by around 9% in both sexes. Available cancer mortality data in Europe up to 2002 allow a first check of the forecast of further declines in cancer mortality. Patients and methods: We considered trends in age-standardised mortality from major cancer sites in the EU during the period 1980-2002. Results: For men, total cancer mortality, after a peak of 191.1/100 000 in 1987 declined to 177.8 in 1997 (-7%), and to 166.5 in 2002. Corresponding figures for females were 107.9/100 000, 100.5 and 95.2, corresponding to falls of 7% from 1987 to 1997, and to 5% from 1997 to 2002. Over the last 5 years, lung cancer declined by 1.9% per year in men, to reach 44.4/100 000, but increased by 1.7% in women, to reach 11.4. In 2002, for the first year, lung cancer mortality in women was higher than that for intestinal cancer (11.1/100 000), and lung cancer became the second site of cancer deaths in women after breast (17.9/100 000). From 1997 to 2002, appreciable declines were observed in mortality from intestinal cancer in men (-1.6% per year, to reach 18.8/100 000), and in women (-2.5%), as well as for breast (-1.7% per year) and prostate cancer (-1.4%). Conclusions: Despite the persisting rises in female lung cancer, the recent trends in cancer mortality in the EU are encouraging and indicate that an 11% reduction in total cancer mortality from 2000 to 2015 is realistic and possible.

AB - Background: From 1988 to 1997 age-standardised total cancer mortality rates in the European Union (EU) fell by around 9% in both sexes. Available cancer mortality data in Europe up to 2002 allow a first check of the forecast of further declines in cancer mortality. Patients and methods: We considered trends in age-standardised mortality from major cancer sites in the EU during the period 1980-2002. Results: For men, total cancer mortality, after a peak of 191.1/100 000 in 1987 declined to 177.8 in 1997 (-7%), and to 166.5 in 2002. Corresponding figures for females were 107.9/100 000, 100.5 and 95.2, corresponding to falls of 7% from 1987 to 1997, and to 5% from 1997 to 2002. Over the last 5 years, lung cancer declined by 1.9% per year in men, to reach 44.4/100 000, but increased by 1.7% in women, to reach 11.4. In 2002, for the first year, lung cancer mortality in women was higher than that for intestinal cancer (11.1/100 000), and lung cancer became the second site of cancer deaths in women after breast (17.9/100 000). From 1997 to 2002, appreciable declines were observed in mortality from intestinal cancer in men (-1.6% per year, to reach 18.8/100 000), and in women (-2.5%), as well as for breast (-1.7% per year) and prostate cancer (-1.4%). Conclusions: Despite the persisting rises in female lung cancer, the recent trends in cancer mortality in the EU are encouraging and indicate that an 11% reduction in total cancer mortality from 2000 to 2015 is realistic and possible.

KW - Cancer

KW - Europe

KW - Mortality

KW - Time trends

UR - http://www.scopus.com/inward/record.url?scp=33847626023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847626023&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdl437

DO - 10.1093/annonc/mdl437

M3 - Article

C2 - 17164227

AN - SCOPUS:33847626023

VL - 18

SP - 593

EP - 595

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 3

ER -